CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER)

The CBER is the center in the FDA responsible for the following:

  • Acceptance and review of an investigational new drug application (INDA) prior to initiating a clinical trial;


  • Establishment inspection;


  • Review and issuance of a biologics license;


  • Post-marketing surveillance of approved biologics.

BACK